<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Health care providers and patients have lots of choice to treat type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but the blood <z:chebi fb="105" ids="17234">glucose</z:chebi> improvement is limited </plain></SENT>
<SENT sid="1" pm="."><plain>The one therapy with unlimited potential (at least theoretically) is insulin </plain></SENT>
<SENT sid="2" pm="."><plain>Many studies show that <z:chebi fb="105" ids="17234">glucose</z:chebi> control is achievable with insulin safely in most patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Effective <z:mp ids='MP_0002055'>diabetes</z:mp> management at the primary care or specialty level requires a belief in the importance of insulin therapy in uncontrolled patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>This review details the theories, observed outcomes, and how-tos regarding insulin use in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>